Detalhe da pesquisa
1.
[A Recurrent Colon Cancer Successfully Treated by Nivolumab plus Ipilimumab with On and Off for Preventing Exacerbation of Skin Disorders].
Gan To Kagaku Ryoho
; 50(10): 1107-1110, 2023 Oct.
Artigo
Japonês
| MEDLINE | ID: mdl-38035846